Safe Orthopaedics posted 3Q18 revenue of €0.8MM (~US $0.9MM), +20% vs. 3Q17, with YTD18 revenue of €2.4MM (~$2.8M), +7% vs. YTD17.
3Q18
3Q17
$ Change
% Change
Spine ($MM)
$0.9
$0.8
$0.2
20.0%
YTD18
YTD17
$ Change
% Change
Spine ($MM)
$2.8
$2.6
$0.2
7.8%
Sales by geographic region:
3Q18
% Change
YTD18
% Change
France
$0.5
19.0%
$1.5
14.0%
Rest of World
$0.5
21.0%
$1.4
-1.0%
An increase in direct sales in France, Germany and the U.K. was the 3Q18 growth driver. These salesforces generated €512,000, +48% vs. the same period last year. Global distribution made headway in Europe (+28%) and Latin America (+148%), but lagged in the Middle East and Asia Pacific (-77%).
Territories in France were redefined to accommodate new 3Q18 sales hires, who started work in 4Q—with training on the SteriSpine VA Vertebral Augmentation system, which launched in late 3Q.
The U.K. salesforce, acquired from Qspine in 2Q, is now contributing in 2H18 as expected.
In Germany, the company appointed Mr. Holger Duerr as Head of Sales. Mr. Duerr has 12 years of kyphoplasty experience, having held sales and leadership positions at Dfine, Kyphon and Vexim.
Safe Orthopaedics posted 3Q18 revenue of €0.8MM (~US $0.9MM), +20% vs. 3Q17, with YTD18 revenue of €2.4MM (~$2.8M), +7% vs. YTD17.
Q18 Q17 $ Change % Change
Spine ($MM) $0.9 $0.8 ...
Safe Orthopaedics posted 3Q18 revenue of €0.8MM (~US $0.9MM), +20% vs. 3Q17, with YTD18 revenue of €2.4MM (~$2.8M), +7% vs. YTD17.
3Q18
3Q17
$ Change
% Change
Spine ($MM)
$0.9
$0.8
$0.2
20.0%
YTD18
YTD17
$ Change
% Change
Spine ($MM)
$2.8
$2.6
$0.2
7.8%
Sales by geographic region:
3Q18
% Change
YTD18
% Change
France
$0.5
19.0%
$1.5
14.0%
Rest of World
$0.5
21.0%
$1.4
-1.0%
An increase in direct sales in France, Germany and the U.K. was the 3Q18 growth driver. These salesforces generated €512,000, +48% vs. the same period last year. Global distribution made headway in Europe (+28%) and Latin America (+148%), but lagged in the Middle East and Asia Pacific (-77%).
Territories in France were redefined to accommodate new 3Q18 sales hires, who started work in 4Q—with training on the SteriSpine VA Vertebral Augmentation system, which launched in late 3Q.
The U.K. salesforce, acquired from Qspine in 2Q, is now contributing in 2H18 as expected.
In Germany, the company appointed Mr. Holger Duerr as Head of Sales. Mr. Duerr has 12 years of kyphoplasty experience, having held sales and leadership positions at Dfine, Kyphon and Vexim.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
